Targeting plasminogen activator inhibitor-1: role in cell signaling and the biology of domain-specific knock-in mice.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Current Drug Targets

• Publication date

  2007-08-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/138945007781662382PMID 17896950
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phosphatidylinositol 3-kinase/Akt regulates the balance between plasminogen activator inhibitor-1 and urokinase to promote migration of SKOV-3 ovarian cancer cells.

  2007cited by this paper
• Endogenous NO Regulates Plasminogen Activator Inhibitor-1 During Angiotensin-Converting Enzyme Inhibition

  2006cited by this paper
• Transforming Growth Factor Beta 1 Induces Neointima Formation Through Plasminogen Activator Inhibitor-1–Dependent Pathways

  2006cited by this paper
• N-acetylcysteine attenuates TNF-alpha induced changes in secretion of interleukin-6, plasminogen activator inhibitor-1 and adiponectin from 3T3-L1 adipocytes.

  2006cited by this paper
• Antihypertensive drugs and fibrinolytic function.

  2006cited by this paper
• A Novel Function of Plasminogen Activator Inhibitor-1 in Modulation of the AKT Pathway in Wild-type and Plasminogen Activator Inhibitor-1-deficient Endothelial Cells*

  2006cited by this paper
• Tumor necrosis factor-alpha-induced production of plasminogen activator inhibitor 1 and its regulation by pioglitazone and cerivastatin in a nonmalignant human hepatocyte cell line.

  2006cited by this paper
• Plasminogen activator inhibitor type-1-deficient mice have an enhanced IFN-gamma response to lipopolysaccharide and staphylococcal enterotoxin B.

  2006cited by this paper
• Role of p90 Ribosomal S6-Kinase-1 in Oltipraz-Induced Specific Phosphorylation of CCAAT/Enhancer Binding Protein-β for GSTA2 Gene Transactivation

  2006cited by this paper
• TGF-beta 1-induced PAI-1 expression is E box/USF-dependent and requires EGFR signaling.

  2006cited by this paper
• The role of plasminogen activator inhibitor type 1 in the inflammatory response to local tissue injury

  2005cited by this paper
• Plasminogen activator inhibitor-1 deficiency retards diabetic nephropathy.

  2005cited by this paper
• Plasminogen activator inhibitor-1 gene deficiency attenuates TGF-beta1-induced kidney disease.

  2005cited by this paper
• Rho/Rho-Kinase Pathway Contributes to C-Reactive Protein–Induced Plasminogen Activator Inhibitor-1 Expression in Endothelial Cells

  2005cited by this paper
• Angiotensin II and the Endothelium: Diverse Signals and Effects

  2005cited by this paper
• Evaluation of PAI-039 [{1-Benzyl-5-[4-(trifluoromethoxy)phenyl]-1H-indol-3-yl}(oxo)acetic Acid], a Novel Plasminogen Activator Inhibitor-1 Inhibitor, in a Canine Model of Coronary Artery Thrombosis

  2005cited by this paper
• Transcriptional regulation of plasminogen activator inhibitor-1 expression by insulin-like growth factor-1 via MAP kinases and hypoxia-inducible factor-1 in HepG2 cells

  2005cited by this paper
• Transcriptional profiling after bile duct ligation identifies PAI‐1 as a contributor to cholestatic injury in mice

  2005cited by this paper
• Inflammatory Cytokines Interleukin-6 and Oncostatin M Induce Plasminogen Activator Inhibitor-1 in Human Adipose Tissue

  2005cited by this paper
• [Rho/Rho kinase signal transduction pathway in cardiovascular disease and cardiovascular remodeling].

  2005cited by this paper
• The Low Density Lipoprotein Receptor-related Protein Is a Motogenic Receptor for Plasminogen Activator Inhibitor-1*

  2004cited by this paper
• Conservation of Critical Functional Domains in Murine Plasminogen Activator Inhibitor-1*

  2004cited by this paper
• Enhanced in Vitro Proliferation of Aortic Endothelial Cells from Plasminogen Activator Inhibitor-1-deficient Mice*

  2004cited by this paper
• Crosstalk of hypoxia‐mediated signaling pathways in upregulating plasminogen activator inhibitor‐1 expression in keloid fibroblasts

  2004cited by this paper
• Transforming growth factor-beta1-dependent activation of Smad2/3 and up-regulation of PAI-1 expression is negatively regulated by Src in SKOV-3 human ovarian cancer cells.

  2004cited by this paper
• Direct attenuation of plasminogen activator inhibitor type-1 expression in human adipose tissue by thiazolidinediones

  2004cited by this paper
• Angiotensin-Converting Enzyme Is Involved in Outside-In Signaling in Endothelial Cells

  2004cited by this paper
• Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth

  2004cited by this paper
• Identification and modulation of a caveolae-dependent signal pathway that regulates plasminogen activator inhibitor-1 in insulin-resistant adipocytes.

  2004cited by this paper
• Interferon-gamma: an overview of signals, mechanisms and functions.

  2004cited by this paper
• Cross‐talk between ERK MAP kinase and Smad‐signaling pathways enhances TGF‐β dependent responses in human mesangial cells

  2003cited by this paper
• Relationship of total and abdominal adiposity with CRP and IL-6 in women.

  2003cited by this paper
• Metastasis of transgenic breast cancer in plasminogen activator inhibitor-1 gene-deficient mice

  2003cited by this paper
• Vascular smooth muscle cell activation by C-reactive protein.

  2003cited by this paper
• C-Reactive Protein Increases Plasminogen Activator Inhibitor-1 Expression and Activity in Human Aortic Endothelial Cells: Implications for the Metabolic Syndrome and Atherothrombosis

  2003cited by this paper
• C-reactive protein activates the nuclear factor-kappaB signal transduction pathway in saphenous vein endothelial cells: implications for atherosclerosis and restenosis.

  2003cited by this paper
• Hypoxia-inducible factor-1 and hypoxia response elements mediate the induction of plasminogen activator inhibitor-1 gene expression by insulin in primary rat hepatocytes.

  2003cited by this paper
• Dose-dependent modulation of choroidal neovascularization by plasminogen activator inhibitor type I: implications for clinical trials.

  2003cited by this paper
• Increased expression of plasminogen activator inhibitor-1 by mediators of the acute phase response: a potential progenitor of vasculopathy in hypertensives.

  2003cited by this paper
• Type 1 plasminogen activator inhibitor deficiency aggravates the course of experimental glomerulonephritis through overactivation of transforming growth factor β

  2003cited by this paper
• Tumor necrosis factor-alpha and troglitazone regulate plasminogen activator inhibitor type 1 production through extracellular signal-regulated kinase- and nuclear factor-kappaB-dependent pathways in cultured human umbilical vein endothelial cells.

  2003cited by this paper
• Plasminogen activator inhibitor-1 in tumor growth, angiogenesis and vascular remodeling.

  2003cited by this paper
• Mechanism of plasminogen activator inhibitor‐1 regulation by oncostatin M and interleukin‐1 in human astrocytes

  2002cited by this paper
• Oncostatin M induces tissue-type plasminogen activator and plasminogen activator inhibitor-1 in Calu-1 lung carcinoma cells.

  2002cited by this paper
• The pro‐ or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent

  2002cited by this paper
• Forkhead transcription factors: key players in development and metabolism.

  2002cited by this paper
• CK2 Phosphorylates the Angiotensin-Converting Enzyme and Regulates Its Retention in the Endothelial Cell Plasma Membrane

  2002cited by this paper
• Involvement of Rho-kinase pathway for angiotensin II-induced plasminogen activator inhibitor-1 gene expression and cardiovascular remodeling in hypertensive rats.

  2002cited by this paper
• Plasminogen activator inhibitor 1 expression is regulated by the inflammatory mediators interleukin-1alpha, tumor necrosis factor-alpha, transforming growth factor-beta and oncostatin M in human cardiac myocytes.

  2002cited by this paper
• Retinoids Induce the PAI-1 Gene Expression Through Tyrosine Kinase-Dependent Pathways in Vascular Smooth Muscle Cells

  2002cited by this paper
• Cerivastatin, a HMG-CoA reductase inhibitor, reduces plasminogen activator inhibitor-1 (PAI-1) expression in endothelial cells by down-regulation of cellular signaling and the inhibition of PAI-1 promoter activity.

  2002cited by this paper
• Restoration of TGF-beta regulation of plasminogen activator inhibitor-1 in Smad3-restituted human choriocarcinoma cells.

  2002cited by this paper
• Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.

  2002cited by this paper
• Identification of a tightly regulated hypoxia-response element in the promoter of human plasminogen activator inhibitor-1.

  2002cited by this paper
• Epithelial monolayer wounding stimulates binding of USF-1 to an E-box motif in the plasminogen activator inhibitor type 1 gene

  2002cited by this paper
• Angiotensin and vascular fibrinolytic balance.

  2002cited by this paper
• Targets of transcriptional regulation by two distinct type I receptors for transforming growth factor‐β in human umbilical vein endothelial cells

  2002cited by this paper
• Platelet-derived Growth Factor (PDGF)-induced Tyrosine Phosphorylation of the Low Density Lipoprotein Receptor-related Protein (LRP)

  2002cited by this paper
• Oltipraz regenerates cirrhotic liver through CCAAT/enhancer binding protein-mediated stellate cell inactivation.

  2002cited by this paper
• Dedifferentiation of serous ovarian cancer from cystic to solid tumors is associated with increased expression of mRNA for urokinase plasminogen activator (uPA), its receptor (uPAR) and its inhibitor (PAI‐1)

  2001cited by this paper
• Elevation of plasma free PAI-1 levels as an integrated endothelial response to severe burns.

  2001cited by this paper
• The Plasminogen Activator Inhibitor PAI-1 Controls in Vivo Tumor Vascularization by Interaction with Proteases, Not Vitronectin

  2001cited by this paper
• Plasminogen Activator Inhibitor 1 Functions as a Urokinase Response Modifier at the Level of Cell Signaling and Thereby Promotes Mcf-7 Cell Growth

  2001cited by this paper
• Inhibition of Angiogenesis in Vivo by Plasminogen Activator Inhibitor-1*

  2001cited by this paper
• LRP: a multifunctional scavenger and signaling receptor.

  2001cited by this paper
• FoxH1 (Fast) functions to specify the anterior primitive streak in the mouse.

  2001cited by this paper
• Plasminogen Activator Inhibitor-1 Regulates Tumor Growth and Angiogenesis*

  2001cited by this paper
• Remodeling of the vessel wall after copper-induced injury is highly attenuated in mice with a total deficiency of plasminogen activator inhibitor-1.

  2001cited by this paper
• Role of the renin-angiotensin system in vascular diseases: expanding the field.

  2001cited by this paper
• Regulation of Plasminogen Activitor Inhibitor-1 in Human Adipose Tissue: Interaction Between Cytokines, Cortisol and Estrogen

  2000cited by this paper
• Hypoxia induces transcription of the plasminogen activator inhibitor-1 gene through genistein-sensitive tyrosine kinase pathways in vascular endothelial cells.

  2000cited by this paper
• Role of cytokines in the regulation of plasminogen activator inhibitor-1 expression and secretion in newly differentiated subcutaneous human adipocytes.

  2000cited by this paper
• Mechanisms of angiogenesis and arteriogenesis

  2000cited by this paper
• Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis.

  2000cited by this paper
• Extracellular signal-regulated kinase functions in the urokinase receptor-dependent pathway by which neutralization of low density lipoprotein receptor-related protein promotes fibrosarcoma cell migration and matrigel invasion.

  2000cited by this paper
• Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1.

  2000cited by this paper
• Heterogeneities in the biological and biochemical functions of Smad2 and Smad4 mutants naturally occurring in human lung cancers

  2000cited by this paper
• Regulation of plasminogen activation by TGF-β in cultured human retinal endothelial cells

  2000cited by this paper
• Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects.

  2000cited by this paper
• Urokinase-type Plasminogen Activator Stimulates the Ras/Extracellular Signal-regulated Kinase (ERK) Signaling Pathway and MCF-7 Cell Migration by a Mechanism That Requires Focal Adhesion Kinase, Src, and Shc

  2000cited by this paper
• Suppression of NF-kappaB activation and cytokine production by N-acetylcysteine in pancreatic acinar cells.

  2000cited by this paper
• CLIF, a Novel Cycle-like Factor, Regulates the Circadian Oscillation of Plasminogen Activator Inhibitor-1 Gene Expression*

  2000cited by this paper
• Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study.

  1999cited by this paper
• On the nature of hypertrophic scars and keloids: a review.

  1999cited by this paper
• On the role of c-Jun in the induction of PAI-1 gene expression by phorbol ester, serum, and IL-1alpha in HepG2 cells.

  1999cited by this paper
• Urokinase-type plasminogen activator binding to its receptor stimulates tumor cell migration by enhancing integrin-mediated signal transduction.

  1999cited by this paper
• New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway.

  1999cited by this paper
• Thiazolidinediones down-regulate plasminogen activator inhibitor type 1 expression in human vascular endothelial cells: A possible role for PPARgamma in endothelial function.

  1999cited by this paper
• Fibroblast response to hypoxia: the relationship between angiogenesis and matrix regulation.

  1999cited by this paper
• Vascular effects of estrogen and vitamin E therapies in postmenopausal women.

  1999cited by this paper
• Assignment of transforming growth factor beta1 and beta3 and a third new ligand to the type I receptor ALK-1.

  1999cited by this paper
• Oncostatin M: Development of a Pleiotropic Cytokine

  1999cited by this paper
• Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway.

  1999cited by this paper
• Urokinase-induced mitogenesis is mediated by casein kinase 2 and nucleolin.

  1999cited by this paper
• Contrasting post-traumatic serial changes for D-dimer and PAI-1 in critically injured patients.

  1999cited by this paper
• Myosin Light Chain Kinase Functions Downstream of Ras/ERK to Promote Migration of Urokinase-Type Plasminogen Activator-Stimulated Cells in an Integrin-Selective Manner

  1999cited by this paper
• Interleukin-6-Specific Activation of the C/EBPδ Gene in Hepatocytes Is Mediated by Stat3 and Sp1

  1998cited by this paper
• Transforming growth factor beta2 in the vitreous in proliferative diabetic retinopathy.

  1998cited by this paper
• N-acetyl cysteine inhibits induction of no production by endotoxin or cytokine stimulated rat peritoneal macrophages, C6 glial cells and astrocytes.

  1998cited by this paper
• Direct binding of Smad3 and Smad4 to critical TGFβ‐inducible elements in the promoter of human plasminogen activator inhibitor‐type 1 gene

  1998cited by this paper

• Recent advances and future perspectives in small molecule JAK2 inhibitors.

  2025cites this paper
• A Contemporary Review of Plasminogen Activator Inhibitor Type 1: Structure, Function, Genetic Architecture, and Intracellular/Extracellular Roles

  2025cites this paper
• Effects of Fermented Rice Vinegar Kurozu and Its Sediment on Inflammation-Induced Plasminogen Activator Inhibitor 1 (PAI-1) Increase

  2018cites this paper
• Plasminogen Activator Inhibitor-1 Suppresses Profibrotic Responses in Fibroblasts from Fibrotic Lungs*

  2015cites this paper
• 4 G/4 G polymorphism of plasminogen activator inhibitor-1 gene increases the risk of diabetic nephropathy

  2014cites this paper
• Functional Stability of Plasminogen Activator Inhibitor-1

  2014cites this paper
• Remarkable stabilization of plasminogen activator inhibitor 1 in a "molecular sandwich" complex.

  2013cites this paper
• Complex Regulation of the Pericellular Proteolytic Microenvironment during Tumor Progression and Wound Repair: Functional Interactions between the Serine Protease and Matrix Metalloproteinase Cascades

  2012cites this paper
• PAI-1: An Integrator of Cell Signaling and Migration

  2011influential citation
• Plasminogen activator inhibitor-1 (PAI-1) is cardioprotective in mice by maintaining microvascular integrity and cardiac architecture.

  2010cites this paper
• pAI-1: A Multifunctional seRpIn with complex Roles in cell signaling and Migration

  2010cites this paper
• Induction of tissue factor by urokinase in lung epithelial cells and in the lungs.

  2010cites this paper
• Improved Autograft Survival of Mesenchymal Stromal Cells by Plasminogen Activator Inhibitor 1 Inhibition

  2009cites this paper
• TGF-beta system: the principal profibrotic mediator of peritoneal adhesion formation.

  2008cites this paper
• Regulation of plasminogen activator inhibitor type 1 gene expression by inflammatory mediators and statins

  2008cites this paper
• TGF-β System: The Principal Profibrotic Mediator of Peritoneal Adhesion Formation

  2008cites this paper
• A Contemporary Review of Plasminogen Activator Inhibitor Type 1: Structure, Function, Genetic Architecture, and Intracellular/Extracellular Roles

  year unknowncites this paper
• A Contemporary Review of Plasminogen Activator Inhibitor Type 1: Structure, Function, Genetic Architecture, and Intracellular/Extracellular Roles

  year unknowncites this paper
• A Contemporary Review of Plasminogen Activator Inhibitor Type 1: Structure, Function, Genetic Architecture, and Intracellular/Extracellular Roles

  year unknowncites this paper